Ping-Li Sun

667 total citations
17 papers, 531 citations indexed

About

Ping-Li Sun is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Ping-Li Sun has authored 17 papers receiving a total of 531 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 11 papers in Oncology and 10 papers in Molecular Biology. Recurrent topics in Ping-Li Sun's work include Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Ping-Li Sun is often cited by papers focused on Lung Cancer Treatments and Mutations (11 papers), Lung Cancer Research Studies (6 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Ping-Li Sun collaborates with scholars based in South Korea, China and Ethiopia. Ping-Li Sun's co-authors include Jin-Haeng Chung, Sanghoon Jheon, Hyojin Kim, Xianhua Xu, Kwhanmien Kim, Eunhyang Park, An Na Seo, Yan Jin, Seol Bong Yoo and Yan Jin and has published in prestigious journals such as Annals of Surgical Oncology, Oncotarget and Journal of Thoracic Oncology.

In The Last Decade

Ping-Li Sun

16 papers receiving 521 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ping-Li Sun South Korea 13 316 261 227 128 49 17 531
Verena Sailer Germany 12 244 0.8× 283 1.1× 169 0.7× 150 1.2× 41 0.8× 20 515
Jan Nyrop Jakobsen Denmark 10 284 0.9× 153 0.6× 195 0.9× 111 0.9× 36 0.7× 18 474
Seol Bong Yoo South Korea 10 338 1.1× 155 0.6× 261 1.1× 114 0.9× 34 0.7× 15 481
Celina Sanchez Rivers Australia 4 199 0.6× 280 1.1× 226 1.0× 141 1.1× 24 0.5× 4 488
Tambudzai Shamu United States 6 293 0.9× 246 0.9× 74 0.3× 101 0.8× 61 1.2× 7 506
Satoshi Taga Japan 10 251 0.8× 217 0.8× 191 0.8× 113 0.9× 56 1.1× 18 514
Nirit Yarom Israel 11 118 0.4× 269 1.0× 145 0.6× 168 1.3× 38 0.8× 23 463
Cristina Niccoli Italy 11 140 0.4× 156 0.6× 150 0.7× 129 1.0× 72 1.5× 19 393
Maria Mihaela Mina Italy 8 155 0.5× 184 0.7× 168 0.7× 113 0.9× 41 0.8× 13 363
Keiko Ohgino Japan 9 254 0.8× 322 1.2× 190 0.8× 113 0.9× 24 0.5× 24 471

Countries citing papers authored by Ping-Li Sun

Since Specialization
Citations

This map shows the geographic impact of Ping-Li Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ping-Li Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ping-Li Sun more than expected).

Fields of papers citing papers by Ping-Li Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ping-Li Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ping-Li Sun. The network helps show where Ping-Li Sun may publish in the future.

Co-authorship network of co-authors of Ping-Li Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Ping-Li Sun. A scholar is included among the top collaborators of Ping-Li Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ping-Li Sun. Ping-Li Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
2.
Cao, Lanqing, Min Yao, Hironobu Sasano, Ping-Li Sun, & Hongwen Gao. (2020). YAP increases response to Trastuzumab in HER2-positive Breast Cancer by enhancing P73-induced apoptosis. Journal of Cancer. 11(22). 6748–6759. 7 indexed citations
3.
Yun, Sumi, Ping-Li Sun, Yan Jin, et al.. (2016). Aquaporin 1 Is an Independent Marker of Poor Prognosis in Lung Adenocarcinoma. Journal of Pathology and Translational Medicine. 50(4). 251–257. 23 indexed citations
4.
Park, Eunhyang, Soo Young Park, Ping-Li Sun, et al.. (2016). Prognostic significance of stem cell-related marker expression and its correlation with histologic subtypes in lung adenocarcinoma. Oncotarget. 7(27). 42502–42512. 43 indexed citations
5.
Jin, Yan, Ping-Li Sun, Soo Young Park, et al.. (2015). Frequent aerogenous spread with decreased E-cadherin expression of ROS1- rearranged lung cancer predicts poor disease-free survival. Lung Cancer. 89(3). 343–349. 34 indexed citations
6.
Sun, Ping-Li, Yan Jin, Soo Young Park, et al.. (2015). Expression of Na+–K+-2Clcotransporter isoform 1 (NKCC1) predicts poor prognosis in lung adenocarcinoma andEGFR-mutated adenocarcinoma patients. QJM. 109(4). 237–244. 17 indexed citations
7.
Park, Eunhyang, Soo Young Park, Hyojin Kim, et al.. (2015). Membranous Insulin-like Growth Factor-1 Receptor (IGF1R) Expression Is Predictive of Poor Prognosis in Patients with Epidermal Growth Factor Receptor (<i>EGFR</i>)-Mutant Lung Adenocarcinoma. Journal of Pathology and Translational Medicine. 49(5). 382–388. 19 indexed citations
8.
Jin, Yan, Ping-Li Sun, Hyojin Kim, et al.. (2014). ROS1 gene rearrangement and copy number gain in non-small cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 466(1). 45–52. 21 indexed citations
9.
Seo, An Na, Yan Jin, Hee Jin Lee, et al.. (2014). FGFR1 amplification is associated with poor prognosis and smoking in non-small-cell lung cancer. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 465(5). 547–558. 59 indexed citations
10.
Xu, Xianhua, Ji Eun Kim, Ping-Li Sun, et al.. (2014). Immunohistochemical demonstration of alteration of β-catenin during tumor metastasis by different mechanisms according to histology in lung cancer. Experimental and Therapeutic Medicine. 9(2). 311–318. 6 indexed citations
11.
Sun, Ping-Li, Yan Jin, Hyojin Kim, et al.. (2013). Survivin expression is an independent poor prognostic marker in lung adenocarcinoma but not in squamous cell carcinoma. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 463(3). 427–436. 21 indexed citations
12.
Jin, Yan, Ping-Li Sun, Hyojin Kim, et al.. (2013). MET Gene Copy Number Gain is an Independent Poor Prognostic Marker in Korean Stage I Lung Adenocarcinomas. Annals of Surgical Oncology. 21(2). 621–628. 13 indexed citations
13.
Yoo, Seol Bong, Yu Jung Kim, Hyojin Kim, et al.. (2013). Alteration of the E-cadherin/β-Catenin Complex Predicts Poor Response to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor (EGFR-TKI) Treatment. Annals of Surgical Oncology. 20(S3). 545–552. 16 indexed citations
16.
Xu, Xianhua, et al.. (2011). Aberrant Wnt1/β-Catenin Expression is an Independent Poor Prognostic Marker of Non-small Cell Lung Cancer After Surgery. Journal of Thoracic Oncology. 6(4). 716–724. 81 indexed citations
17.
Kim, Hyojin, Xianhua Xu, Ping-Li Sun, et al.. (2011). Clinicopathologic Implications of ALK Gene Copy Number Gain in Non-small Cell Lung Cancer. 10(2). 87–87. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026